|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.13 USD | +0.27% |
|
-.--% | - |
| 28/07/25 | Verve Therapeutics, Inc.(NasdaqGS:VERV) dropped from S&P Biotechnology Select Industry Index | CI |
| 28/07/25 | Verve Therapeutics, Inc.(NasdaqGS:VERV) dropped from S&P Global BMI Index | CI |
| Market Cap | 994M 872M 808M 743M 1.41B 95.15B 1.43B 9.63B 3.78B 46.73B 3.73B 3.65B 161B | P/E 2023 |
-4.47x | P/E 2024 | -2.4x |
|---|---|---|---|---|---|
| Enterprise Value | 540M 473M 439M 404M 763M 51.67B 778M 5.23B 2.05B 25.37B 2.03B 1.98B 87.63B | EV / Sales 2023 |
46,430,598x | EV / Sales 2024 | 717,743x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +0.27% |
| 1 year | 10.9 |  | 11.25 |
| 3 years | 2.86 | | 21.04 |
| 5 years | 2.86 | | 78 |
| 10 years | 2.86 | | 78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Haug
PSD | President | - | 25/07/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/07/25 | Tender | Chief Financial Officer | 1,079,102 | 1.2746% | ||
| 25/07/25 | Issuer sale | Director | 178,339 | 0.2106% | ||
| 25/07/25 | Tender | Founder | 649,863 | 0.7676% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 11.76 10.31 9.55 8.79 16.62 1.13K 16.95 113.84 44.65 552.65 44.15 43.19 1.91K | 32.33 28.36 26.27 24.17 45.71 3.09K 46.6 313.04 122.78 1.52K 121.41 118.76 5.25K |
| Net income | -200M -175M -163M -150M -283M -19.15B -288M -1.94B -760M -9.4B -751M -735M -32.48B | -199M -174M -161M -149M -281M -19.02B -286M -1.92B -755M -9.34B -746M -730M -32.25B |
| Net Debt | -549M -482M -446M -410M -776M -52.55B -791M -5.32B -2.08B -25.81B -2.06B -2.02B -89.12B | -454M -398M -369M -340M -642M -43.48B -655M -4.4B -1.73B -21.35B -1.71B -1.67B -73.74B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- VERV Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
